Back to Archived News
Health Enhancement Products, Inc. Receives Notice of Allowance from US Patent Office for its Proprietary Algae Extract
Wednesday, June 02, 2010
Company Solidifies Its Intellectual Property Portfolio with Official Patent Office Notice
Scottsdale, AZ -- Health Enhancement Products, Inc. (OTCBB: HEPI) was given a “Notice of Allowance” by the U.S. Patent & Trademark Office, after which a formal notice of patent issuance will follow. Once issued the patent will provide intellectual property protection for the Company’s proprietary algae extract, specifically as it applies to addressing a wide range of conditions and illnesses.
“This is a critical milestone for our Company as we build a solid body of nutritional science that will allow us to enter the food ingredient and nutraceutical industry with new credible and effective natural products,” says John Gorman, HEPI’s Director and board member. “We will be providing more detail at the June 8 press event in New York City at the New York Athletic Club.”
“The algae extract is shown to be effective when taken orally administered in liquid form and is stable, not easily degraded and maintains bioactivity in air as well as at room temperature,” notes HEPI Chief Scientific Officer, Denis Callewaert, PhD. “These are unique and ideal characteristics for a successful food ingredient.”
HEPI will host a scientific panel in New York at noon on Tuesday, June 8, 2010 at the New York Athletic Club with Dr. Smiti Gupta, assistant professor of nutrition and food sciences at Wayne State University and principal investigator of the cholesterol study. Other scientists presenting will include Dr. Fazlul Sarkar, Dr. Denis Callewaert, and Dr. Donald Armstrong.
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTCBB:HEPI) is a health & wellness company engaged in the development of products comprised of pure, all-natural compounds that can be used as a dietary supplement and food additive. The Company's product is ProAlgaZyme® (PAZ™), a liquid product drawn from living algae grown in purified water. The water in which the algae are grown is drawn off, filtered and bottled under the trademark ProAlgaZyme®.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
For more information, please visit http://www.heponline.com.
Back to Archived News